Use of dupilumab in the management of refractory prurigo nodularis in an immunosuppressed double transplanted patient
Anais Brasileiros de Dermatologia · 2026-05 · 101 (3) · 501358
DOI: 10.1016/j.abd.2026.501358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-05. Verfasst von Diego Valenzuela Godoy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universidad de los Andes, Santiago, Chile. Electronic address: davalenzuela1@miuandes.cl. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Medicine, Universidad de los Andes, Santiago, Chile. Electronic address: davalenzuela1@miuandes.cl.
- Department of Dermatology, Faculty of Medicine, Universidad de los Andes, Santiago, Chile.
- Department of Dermatology, Faculty of Medicine, Universidad de los Andes, Santiago, Chile; Department of Dermatology, Clínica Universidad de los Andes, Santiago, Chile.
Zitieren
APA
Valenzuela Godoy, D., Agüero, R., & Kolbach, M. (2026). Use of dupilumab in the management of refractory prurigo nodularis in an immunosuppressed double transplanted patient. Anais Brasileiros de Dermatologia, 101(3), 501358. https://doi.org/10.1016/j.abd.2026.501358
Vancouver
Valenzuela Godoy D, Agüero R, Kolbach M. Use of dupilumab in the management of refractory prurigo nodularis in an immunosuppressed double transplanted patient. Anais Brasileiros de Dermatologia. 2026;101(3):501358. doi:10.1016/j.abd.2026.501358
BibTeX
@article{ValenzuelaGodoy2026,
author = {Valenzuela Godoy, Diego and Agüero, Rosario and Kolbach, Marianne},
title = {Use of dupilumab in the management of refractory prurigo nodularis in an immunosuppressed double transplanted patient},
journal = {Anais Brasileiros de Dermatologia},
year = {2026},
volume = {101},
number = {3},
pages = {501358},
doi = {10.1016/j.abd.2026.501358}
}
EUVIMED